10x Genomics, Inc. Class A Common Stock TXG
$47.27
-4.37%
at last close
Financials (TTM)
- Revenue
- $638.78 million
- Net Income
- $-22,656,000
- Net Margin
- -3.55%
- Return on Equity
- -2.78%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 7.37
- Price / Sales
- 9.39
Over the trailing twelve months, 10x Genomics, Inc. Class A Common Stock generated revenue of $638.78 million and net income of $-22,656,000, a net margin of -3.55%.
At the last closing price of $47.27, TXG trades at 9.39 times sales, with a market capitalization of $6.00 billion.
Key Stats
- Last Close
- $47.27
- Market Cap
- $6.00 billion
- 52-Week Range
- $11.16 – $50.34
- Average Volume
- 3.17 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.